A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016)

作者: Marta Moreira , Olga Castro , Melissa Palmieri , Sofia Efklidou , Stefano Castagna

DOI: 10.1080/21645515.2016.1263409

关键词: Pneumococcal diseasePediatricsIncidence (epidemiology)Vaccination coveragePneumococcal conjugate vaccineMedicinePrivate marketVaccinationPneumococcal conjugate vaccinationClinical effectiveness

摘要: ABSTRACTHigher-valent pneumococcal conjugate vaccines (PCVs) were licensed from 2009 in Europe; similar worldwide clinical effectiveness was observed for PCVs routine use. Despite a proven medical need, PCV vaccination Southern Europe remained suboptimal until 2015/16.We searched PubMed manuscripts published between and mid-2016. Included had to contain data about invasive disease (IPD) incidence, or coverage with higher-valent PCVs. This review represents the first analysis of impact on overall IPD European countries (Portugal, Spain, Italy, Greece, Cyprus).Vaccination Portuguese private market peaked around 2008 at 75% (children ≤ 2 years) but declined 63% 2012. In Madrid, 95% (2007–2012) dropped 67% (2013/14; children after funding termination May recently introduced national immunisation program (NIP) Portugal (...

参考文章(39)
Emanuele Amodio, Francesco Vitale, Stefania Stefani, Antonino Bella, Giuseppe Nicoletti, [Active surveillance of invasive pneumococcal diseases in Sicilian children (2009-2011)]. Igiene e sanità pubblica. ,vol. 69, pp. 79- 90 ,(2013)
Francesca Fortunato, Domenico Martinelli, Maria Giovanna Cappelli, Vanessa Cozza, Rosa Prato, Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children Clinical & Developmental Immunology. ,vol. 2015, pp. 206757- 206757 ,(2015) , 10.1155/2015/206757
Adoración Navarro-Torné, Joana Gomes Dias, Frantiska Hruba, Pier Luigi Lopalco, Lucia Pastore-Celentano, Andrew J Amato Gauci, Invasive Pneumococcal Disease Study Group, None, Risk factors for death from invasive pneumococcal disease, Europe, 2010. Emerging Infectious Diseases. ,vol. 21, pp. 417- 425 ,(2015) , 10.3201/EID2103.140634
Walter Massa Ramalho, Indianara Maria Grando, Diana Lucia Moura Pinho, Brendan Flannery, Marco Aurélio P. Horta, Gilmara Lima Nascimento, Camile de Moraes, Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil Cadernos De Saude Publica. ,vol. 31, pp. 276- 284 ,(2015) , 10.1590/0102-311X00169913
P.L. Lopalco, P. Carrillo Santisteve, Actual immunization coverage throughout Europe: are existing data sufficient? Clinical Microbiology and Infection. ,vol. 20, pp. 7- 11 ,(2014) , 10.1111/1469-0691.12453
Domenico Martinelli, Biagio Pedalino, Maria Giovanna Cappelli, Giovanni Caputi, Anna Sallustio, Francesca Fortunato, Silvio Tafuri, Vanessa Cozza, Cinzia Germinario, Maria Chironna, Rosa Prato, Apulian Group for the surveillance of pediatric IPD, Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013. Human Vaccines & Immunotherapeutics. ,vol. 10, pp. 33- 39 ,(2014) , 10.4161/HV.26650
Pauline A Waight, Nicholas J Andrews, Shamez N Ladhani, Carmen L Sheppard, Mary P E Slack, Elizabeth Miller, Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study Lancet Infectious Diseases. ,vol. 15, pp. 535- 543 ,(2015) , 10.1016/S1473-3099(15)70044-7